Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00661583 · ClinicalTrials.gov registry record · Phase 1
Use of Ranibizumab With Mitomycin C During Trabeculectomy
A Phase 1 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT00661583 is a Phase 1 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 30 participants.
The verdict
NCT00661583, a Phase 1 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of the study is to study the safety of the combination of ranibizumab and MMC vs monotherapy MMC vs intravitreal ranibizumab injection in patients with glaucoma.
Interventions
- DRUG MMC
- DRUG Ranibizumab
- DRUG Ranibizumab and MMC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-04 |
| Est. Completion | 2014-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00661583
The ClinicalTrials.gov registry entry for NCT00661583 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which MMC is the first listed.
NCT00661583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00661583 about?
NCT00661583 is a clinical study titled "Use of Ranibizumab With Mitomycin C During Trabeculectomy". The purpose of the study is to study the safety of the combination of ranibizumab and MMC vs monotherapy MMC vs intravitreal ranibizumab injection in patients with glaucoma.
What is the current status of trial NCT00661583?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2008-04. Estimated completion is 2014-09.
What interventions are being tested in trial NCT00661583?
The interventions under investigation include: MMC (DRUG), Ranibizumab (DRUG), Ranibizumab and MMC (DRUG).
Who is sponsoring clinical trial NCT00661583?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.